other material
confidence high
sentiment neutral
materiality 0.65
MedAvail Holdings, Inc.: M&A transaction — MedAvail substantially completes exit from pharmacy services; focuses on pharmacy tech business
MedAvail Holdings, Inc.
- As of March 31, 2023, MedAvail substantially completed exit from pharmacy services; future focus solely on pharmacy tech.
- Closed asset sale to CVS on Feb 10, 2023 for $2.9M final purchase price (up to $4.4M originally) with $0.1M fees and $0.2M holdback.
- Pro forma shows elimination of pharmacy services revenue: $30.7M for 9mo Sep2022, $20.2M for FY2021.
- Pro forma net loss reduced to $15.4M (9mo Sep2022) from historical $36.5M; discontinued ops treatment in Q1 2023 10-Q.
- Company now solely a pharmacy technology business after exiting retail pharmacy operations.